Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
Grodzinsky A, Kosiborod M, Tang F, et al.
Circ Cardiovasc Qual Outcomes. Pub. online September 13, 2017.
Leggi
Breaking news
Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes (CONCEPTT): A Multicentre International Randomised Controlled Trial
Feig DS, Donovan LE, Corcoy R, et al. on behalf of the show CONCEPTT Collaborative Group
The Lancet. Pub.online15 September 2017
Leggi
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT-1): 24 Week Results From a Multicentre, Double-Blind, Phase 3, Randomised Controlled Trial
Dandona P, Mathieu C, Phillip M
The Lancet Diabetes & Endocrinology. Pub. online 14 September 2017
Leggi
SGLT2 Inhibitors in Type 1 Diabetes: Knocked Down, But Up Again?
Petrie JR
The Lancet Diabetes & Endocrinology. Pub. online 14 September 2017
Leggi
Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes
Garg SK, Polsky S
The Lancet. Pub.online15 September 2017
Leggi
Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes
Garg SK
Diabetes Technology & Therapeutics. Pub. online September 2017
Leggi
Risk of Atrial Fibrillation in People With Type 1 Diabetes Compared With Matched Controls From The General Population: A Prospective Case-Control Study
Dahlqvist S, Rosengren A, and Gudbjörnsdottir S
The Lancet Diabetes & Endocrinology. 2017;5(10):799-807
Leggi
Adult-Onset Autoimmune Diabetes: Current Knowledge and Implications for Management
Buzzetti R, Zampetti S and Maddaloni E
Nature Reviews Endocrinology. Pub. online 08 September 2017
Leggi
Is Atrial Fibrillation Another Manifestation of Organ Damage in Diabetes?
Miyazawa K and Lip GYH
The Lancet Diabetes & Endocrinology. 2017;5(10):761-2
Leggi
FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing. A Potentially Risky Decision
Shapiro AR
JAMA. Pub. online September 14, 2017
Leggi